testosterone

(redirected from Androderm)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
  • noun

Words related to testosterone

a potent androgenic hormone produced chiefly by the testes

References in periodicals archive ?
SmithKline Beecham has marketing rights to Androderm in the United States, Canada and much of Europe, as well as Australia and New Zealand.
Androderm is the transdermal testosterone delivery system market leader in all countries in which it is currently sold, according to industry prescription tracking reports.
The patented Androderm patch is intended for the treatment of male hypogonadism, a syndrome in which the body produces insufficient amounts of the male hormone, testosterone.
Product Monograph: Androderm Testosterone, Transdermal Delivery System, 122 mg and 243 mg.
The clinical improvements were all the more impressive given that many patients weren't able to take the full prescribed dose of testosterone replacement therapy because of recurrent skin rashes caused by the adhesive used in the 5-mg Androderm patches.
The 29-year-old arrived at the airport on 13 May 2003 and was detained along with a 39-year-old Russian cycling coach after customs officials discovered 30 tablets of the anabolic steroid Stanozolol and two Androderm testosterone patches inside a hard plastic bicycle case.
The Androderm patch, as it is called, will deliver a regular dose of the male sexual hormone testosterone through the skin, directly into the bloodstream.
Bart is currently evaluating cases that involve some of the most commonly prescribed testosterone therapies such as Androgel, Androderm, Android 10, Axiron, Depo-Testosterone, Bio-T-Gel, Delatestryl, Fortesta, Striant, Testim and Testopel.
The 36-year-old arrived at the Australian airport on 13 May 2003 and was detained along with a 29-year-old female cyclist after Australian customs officers discovered 30 tablets of the anabolic steroid Stanozolol and two Androderm testosterone patches inside a hard plastic bicycle case.
PRODUCT LAUNCHES/APPROVALS II-27 HRTI Obtains FDA Clearance for Commencing Testagen TDS Clinical Trials II-27 Eli Lily Launches Axiron in Canada II-27 FDA Approves Generic Depo-Testosterone Injection of Sun Pharmaceutical II-27 Perrigo Obtains FDA Approval for AndroGel 1% II-28 TestoMeds Launches Androfeme, Andromforte and Profeme Testosterone Replacement Creams II-28 BioSante's Bio-T-Gel(TM) Receives FDA Clearance II-28 Eli Lilly Launches Axiron Topical Solution in the US II-29 US FDA Grants Approval Low-Dose Formulations of Watson's Androderm II-29 Abbott Obtains FDA Clearance for AndroGel 1.